Conversion of β-human atrial natriuretic polypeptide into α-human atrial natriuretic polypeptide in human plasma in vitro

Hiroshi Itoh, Kazuwa Nakao, Shozo Shiono, Masashi Mukoyama, Narito Morii, Akira Sugawara, Takayuki Yamada, Yoshihiko Saito, Hiroshi Arai, Yoshikazu Kambayashi, Ken Inouye, Hiroo Imura

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Using synthetic β-human atrial natriuretic polypeptide (β-hANP), an antiparallel dimer of α-hANP, and radioimmunoassay (RIA) for α-ANP which also detects β-hANP, we investigated the disappearance profile and the change in the molecular form of exogenously added β-hANP in human plasma in vitro, compared with those of α-hANP. The ANP-like immunoreactivity (ANP-LI) level in β-hANP-added human plasma exhibited slower disappearance than that in α-hANP-added plasma during the incubation at 37°C. High performance-gel permeation chromatography and reverse phase-high performance liquid chromatography coupled with RIA revealed that β-hANP (6K) was converted into a smaller peptide with an approximate molecular weight of 3K corresponding to α-hANP during the incubation. Amino acid analysis and amino-terminal sequencing confirmed that the converted peptide from β-hANP in human plasma is authentic α-hANP. The demonstrated conversion of β-hANP into α-hANP in human plasma could be relevant to the in vivo natriuretic and diuretic actions with slower onset and longer duration of this unique peptide.

Original languageEnglish
Pages (from-to)560-569
Number of pages10
JournalBiochemical and Biophysical Research Communications
Volume143
Issue number2
DOIs
Publication statusPublished - 1987 Mar 13
Externally publishedYes

Fingerprint

Plasma (human)
Atrial Natriuretic Factor
Peptides
Radioimmunoassay
Gel permeation chromatography
High performance liquid chromatography
Diuretics
Dimers
Molecular weight
Gel Chromatography
Plasmas
Amino Acids
Molecular Weight
High Pressure Liquid Chromatography
In Vitro Techniques

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Conversion of β-human atrial natriuretic polypeptide into α-human atrial natriuretic polypeptide in human plasma in vitro. / Itoh, Hiroshi; Nakao, Kazuwa; Shiono, Shozo; Mukoyama, Masashi; Morii, Narito; Sugawara, Akira; Yamada, Takayuki; Saito, Yoshihiko; Arai, Hiroshi; Kambayashi, Yoshikazu; Inouye, Ken; Imura, Hiroo.

In: Biochemical and Biophysical Research Communications, Vol. 143, No. 2, 13.03.1987, p. 560-569.

Research output: Contribution to journalArticle

Itoh, H, Nakao, K, Shiono, S, Mukoyama, M, Morii, N, Sugawara, A, Yamada, T, Saito, Y, Arai, H, Kambayashi, Y, Inouye, K & Imura, H 1987, 'Conversion of β-human atrial natriuretic polypeptide into α-human atrial natriuretic polypeptide in human plasma in vitro', Biochemical and Biophysical Research Communications, vol. 143, no. 2, pp. 560-569. https://doi.org/10.1016/0006-291X(87)91390-8
Itoh, Hiroshi ; Nakao, Kazuwa ; Shiono, Shozo ; Mukoyama, Masashi ; Morii, Narito ; Sugawara, Akira ; Yamada, Takayuki ; Saito, Yoshihiko ; Arai, Hiroshi ; Kambayashi, Yoshikazu ; Inouye, Ken ; Imura, Hiroo. / Conversion of β-human atrial natriuretic polypeptide into α-human atrial natriuretic polypeptide in human plasma in vitro. In: Biochemical and Biophysical Research Communications. 1987 ; Vol. 143, No. 2. pp. 560-569.
@article{16c11dd162a040c29d8479060b105baf,
title = "Conversion of β-human atrial natriuretic polypeptide into α-human atrial natriuretic polypeptide in human plasma in vitro",
abstract = "Using synthetic β-human atrial natriuretic polypeptide (β-hANP), an antiparallel dimer of α-hANP, and radioimmunoassay (RIA) for α-ANP which also detects β-hANP, we investigated the disappearance profile and the change in the molecular form of exogenously added β-hANP in human plasma in vitro, compared with those of α-hANP. The ANP-like immunoreactivity (ANP-LI) level in β-hANP-added human plasma exhibited slower disappearance than that in α-hANP-added plasma during the incubation at 37°C. High performance-gel permeation chromatography and reverse phase-high performance liquid chromatography coupled with RIA revealed that β-hANP (6K) was converted into a smaller peptide with an approximate molecular weight of 3K corresponding to α-hANP during the incubation. Amino acid analysis and amino-terminal sequencing confirmed that the converted peptide from β-hANP in human plasma is authentic α-hANP. The demonstrated conversion of β-hANP into α-hANP in human plasma could be relevant to the in vivo natriuretic and diuretic actions with slower onset and longer duration of this unique peptide.",
author = "Hiroshi Itoh and Kazuwa Nakao and Shozo Shiono and Masashi Mukoyama and Narito Morii and Akira Sugawara and Takayuki Yamada and Yoshihiko Saito and Hiroshi Arai and Yoshikazu Kambayashi and Ken Inouye and Hiroo Imura",
year = "1987",
month = "3",
day = "13",
doi = "10.1016/0006-291X(87)91390-8",
language = "English",
volume = "143",
pages = "560--569",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Conversion of β-human atrial natriuretic polypeptide into α-human atrial natriuretic polypeptide in human plasma in vitro

AU - Itoh, Hiroshi

AU - Nakao, Kazuwa

AU - Shiono, Shozo

AU - Mukoyama, Masashi

AU - Morii, Narito

AU - Sugawara, Akira

AU - Yamada, Takayuki

AU - Saito, Yoshihiko

AU - Arai, Hiroshi

AU - Kambayashi, Yoshikazu

AU - Inouye, Ken

AU - Imura, Hiroo

PY - 1987/3/13

Y1 - 1987/3/13

N2 - Using synthetic β-human atrial natriuretic polypeptide (β-hANP), an antiparallel dimer of α-hANP, and radioimmunoassay (RIA) for α-ANP which also detects β-hANP, we investigated the disappearance profile and the change in the molecular form of exogenously added β-hANP in human plasma in vitro, compared with those of α-hANP. The ANP-like immunoreactivity (ANP-LI) level in β-hANP-added human plasma exhibited slower disappearance than that in α-hANP-added plasma during the incubation at 37°C. High performance-gel permeation chromatography and reverse phase-high performance liquid chromatography coupled with RIA revealed that β-hANP (6K) was converted into a smaller peptide with an approximate molecular weight of 3K corresponding to α-hANP during the incubation. Amino acid analysis and amino-terminal sequencing confirmed that the converted peptide from β-hANP in human plasma is authentic α-hANP. The demonstrated conversion of β-hANP into α-hANP in human plasma could be relevant to the in vivo natriuretic and diuretic actions with slower onset and longer duration of this unique peptide.

AB - Using synthetic β-human atrial natriuretic polypeptide (β-hANP), an antiparallel dimer of α-hANP, and radioimmunoassay (RIA) for α-ANP which also detects β-hANP, we investigated the disappearance profile and the change in the molecular form of exogenously added β-hANP in human plasma in vitro, compared with those of α-hANP. The ANP-like immunoreactivity (ANP-LI) level in β-hANP-added human plasma exhibited slower disappearance than that in α-hANP-added plasma during the incubation at 37°C. High performance-gel permeation chromatography and reverse phase-high performance liquid chromatography coupled with RIA revealed that β-hANP (6K) was converted into a smaller peptide with an approximate molecular weight of 3K corresponding to α-hANP during the incubation. Amino acid analysis and amino-terminal sequencing confirmed that the converted peptide from β-hANP in human plasma is authentic α-hANP. The demonstrated conversion of β-hANP into α-hANP in human plasma could be relevant to the in vivo natriuretic and diuretic actions with slower onset and longer duration of this unique peptide.

UR - http://www.scopus.com/inward/record.url?scp=0023096418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023096418&partnerID=8YFLogxK

U2 - 10.1016/0006-291X(87)91390-8

DO - 10.1016/0006-291X(87)91390-8

M3 - Article

AN - SCOPUS:0023096418

VL - 143

SP - 560

EP - 569

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -